Genomic Medicine Program Advisory Committee; Notice of Meeting, 14806 [2017-05664]

Download as PDF 14806 Federal Register / Vol. 82, No. 54 / Wednesday, March 22, 2017 / Notices asabaliauskas on DSK3SPTVN1PROD with NOTICES Time: 10:00 a.m. to 4:30 p.m. Location: Conference Room A&B, United States Mint, 801 9th Street NW., Washington, DC 20220. Subject: Review and discussion of candidate designs for the 2018 World War I Armed Forces Silver Medals, and the American Eagle Palladium Bullion Coin; and a discussion of concepts and themes for the Filipino Veterans of World War II Congressional Gold Medal. Interested members of the public may either attend the meeting in person or dial in to listen to the meeting at (866) 564–9287/Access Code: 62956028. Interested persons should call the CCAC HOTLINE at (202) 354–7502 for the latest update on meeting time and room location. Any member of the public interested in submitting matters for the CCAC’s consideration is invited to submit them by fax to the following number: 202– 756–6525. In accordance with 31 U.S.C. 5135, the CCAC: D Advises the Secretary of the Treasury on any theme or design proposals relating to circulating coinage, bullion coinage, Congressional Gold Medals, and national and other medals. D Advises the Secretary of the Treasury with regard to the events, persons, or places to be commemorated by the issuance of commemorative coins in each of the five calendar years succeeding the year in which a commemorative coin designation is made. D Makes recommendations with respect to the mintage level for any commemorative coin recommended. Members of the public interested in attending the meeting in person will be admitted into the meeting room on a first-come, first-serve basis as space is limited. Conference Room A&B can accommodate up to 50 members of the VerDate Sep<11>2014 18:14 Mar 21, 2017 Jkt 241001 public at any one time. In addition, all persons entering a United States Mint facility must adhere to building security protocol. This means they must consent to the search of their persons and objects in their possession while on government grounds and when they enter and leave the facility, and are prohibited from bringing the following items into the facility: D Illegal drugs, drug paraphernalia, and contraband; D Weapons of any type; The United States Mint Police Officer conducting the screening will evaluate whether an item may enter into or exit from a facility based upon federal law, Treasury policy, United States Mint Policy, and local operating procedure; and all prohibited and unauthorized items will be subject to confiscation and disposal. FOR FURTHER INFORMATION CONTACT: Betty Birdsong, Acting United States Mint Liaison to the CCAC; 801 9th Street NW.; Washington, DC 20220; or call 202–354–7200. Authority: 31 U.S.C. 5135(b)(8)(C). Dated: March 15, 2017. David Motl, Acting Principal Deputy Director, United States Mint. [FR Doc. 2017–05512 Filed 3–21–17; 8:45 am] BILLING CODE P DEPARTMENT OF VETERANS AFFAIRS Genomic Medicine Program Advisory Committee; Notice of Meeting The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act, 5 U.S.C. App. 2, that the Genomic Medicine Program Advisory Committee will meet on May 22, 2017, at the Hilton Garden Inn, PO 00000 Frm 00134 Fmt 4703 Sfmt 9990 Washington, DC, U.S. Capitol, 1225 1st Street NE., Washington, DC 20002. The meeting will convene at 9:00 a.m. and adjourn at 4:30 p.m. The meeting is open to the public. The purpose of the Committee is to provide advice and make recommendations to the Secretary of VA on using genetic information to optimize medical care for Veterans and to enhance development of tests and treatments for diseases particularly relevant to Veterans. The Committee will receive program updates and continue to provide insight into optimal ways for VA to incorporate genomic information into its health care program while applying appropriate ethical oversight and protecting the privacy of Veterans. The meeting focus will be on updates on the progress and planned characterization of the Million Veteran Program (MVP) samples and data access for the MVP, as well as updates from other national research programs such as the Kaiser Permanante. The Committee will also receive an update from the VA Clinical Genomics Service. Public comments will be received at 3:30 p.m. and are limited to 5 minutes each. Individuals who speak are invited to submit a 1–2 page summary of their comments for inclusion in the official meeting record to Dr. Sumitra Muralidhar, Designated Federal Officer, 810 Vermont Avenue NW., Washington, DC, 20420, or by email at sumitra.muralidhar@va.gov. Any member of the public seeking additional information should contact Dr. Muralidhar at (202) 443–5679. Dated: March 17, 2017. LaTonya L. Small, Advisory Committee Management Officer. [FR Doc. 2017–05664 Filed 3–21–17; 8:45 am] BILLING CODE P E:\FR\FM\22MRN1.SGM 22MRN1

Agencies

[Federal Register Volume 82, Number 54 (Wednesday, March 22, 2017)]
[Notices]
[Page 14806]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05664]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Genomic Medicine Program Advisory Committee; Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under the 
Federal Advisory Committee Act, 5 U.S.C. App. 2, that the Genomic 
Medicine Program Advisory Committee will meet on May 22, 2017, at the 
Hilton Garden Inn, Washington, DC, U.S. Capitol, 1225 1st Street NE., 
Washington, DC 20002. The meeting will convene at 9:00 a.m. and adjourn 
at 4:30 p.m. The meeting is open to the public.
    The purpose of the Committee is to provide advice and make 
recommendations to the Secretary of VA on using genetic information to 
optimize medical care for Veterans and to enhance development of tests 
and treatments for diseases particularly relevant to Veterans.
    The Committee will receive program updates and continue to provide 
insight into optimal ways for VA to incorporate genomic information 
into its health care program while applying appropriate ethical 
oversight and protecting the privacy of Veterans. The meeting focus 
will be on updates on the progress and planned characterization of the 
Million Veteran Program (MVP) samples and data access for the MVP, as 
well as updates from other national research programs such as the 
Kaiser Permanante. The Committee will also receive an update from the 
VA Clinical Genomics Service. Public comments will be received at 3:30 
p.m. and are limited to 5 minutes each. Individuals who speak are 
invited to submit a 1-2 page summary of their comments for inclusion in 
the official meeting record to Dr. Sumitra Muralidhar, Designated 
Federal Officer, 810 Vermont Avenue NW., Washington, DC, 20420, or by 
email at sumitra.muralidhar@va.gov. Any member of the public seeking 
additional information should contact Dr. Muralidhar at (202) 443-5679.

    Dated: March 17, 2017.
LaTonya L. Small,
Advisory Committee Management Officer.
[FR Doc. 2017-05664 Filed 3-21-17; 8:45 am]
 BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.